These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26195051)

  • 1. Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
    Giovannoni G; Turner B; Gnanapavan S; Offiah C; Schmierer K; Marta M
    Mult Scler Relat Disord; 2015 Jul; 4(4):329-33. PubMed ID: 26195051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDA treatment target? No evident disease activity as an actionable outcome in practice.
    Parks NE; Flanagan EP; Lucchinetti CF; Wingerchuk DM
    J Neurol Sci; 2017 Dec; 383():31-34. PubMed ID: 29246616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.
    Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL
    JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis.
    Giovannoni G; Tomic D; Bright JR; Havrdová E
    Mult Scler; 2017 Aug; 23(9):1179-1187. PubMed ID: 28381105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
    Edan G
    Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain volume loss is present in Japanese multiple sclerosis patients with no evidence of disease activity.
    Yokote H; Kamata T; Toru S; Sanjo N; Yokota T
    Neurol Sci; 2018 Oct; 39(10):1713-1716. PubMed ID: 29974307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of "No Evidence of Disease Activity" in multiple sclerosis.
    Lu G; Beadnall HN; Barton J; Hardy TA; Wang C; Barnett MH
    Mult Scler Relat Disord; 2018 Feb; 20():231-238. PubMed ID: 29579629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "No evidence of disease activity": Is it an aspirational therapeutic goal in multiple sclerosis?
    Mayssam EN; Eid C; Khoury SJ; Hannoun S
    Mult Scler Relat Disord; 2020 May; 40():101935. PubMed ID: 31951861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
    Stuart WH
    J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S19-25. PubMed ID: 15253686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis.
    Monschein T; Salhofer-Polanyi S; Altmann P; Zrzavy T; Dal-Bianco A; Bsteh G; Rommer P; Berger T; Leutmezer F
    J Neurol; 2021 Apr; 268(4):1247-1253. PubMed ID: 32929591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].
    Newsome SD; Binns C; Kaunzner UW; Morgan S; Halper J
    Neurol Ther; 2023 Dec; 12(6):1909-1935. PubMed ID: 37819598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of disease activity in multiple sclerosis patients.
    Matta AP; Nascimento OJ; Ferreira AC; Magalhães TN; Benevides TP; Kirmse A; Dib JG; Cal H; Orsini M; Araujo LM
    Expert Rev Neurother; 2016 Nov; 16(11):1279-1284. PubMed ID: 27352830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'No evidence of disease activity' - is it an appropriate surrogate in multiple sclerosis?
    Hegen H; Bsteh G; Berger T
    Eur J Neurol; 2018 Sep; 25(9):1107-e101. PubMed ID: 29687559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes].
    Brochet B
    Rev Neurol (Paris); 2013 Nov; 169(11):858-63. PubMed ID: 24094530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI to monitor treatment efficacy in multiple sclerosis.
    Fazekas F; Soelberg-Sorensen P; Comi G; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():50S-55S. PubMed ID: 17425736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.
    Tummala S; Singhal T; Oommen VV; Kim G; Khalid F; Healy BC; Bakshi R
    Int J MS Care; 2017; 19(3):158-164. PubMed ID: 28603465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain health: time matters in multiple sclerosis.
    Giovannoni G; Butzkueven H; Dhib-Jalbut S; Hobart J; Kobelt G; Pepper G; Sormani MP; Thalheim C; Traboulsee A; Vollmer T
    Mult Scler Relat Disord; 2016 Sep; 9 Suppl 1():S5-S48. PubMed ID: 27640924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
    J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using MRI to make informed clinical decisions in multiple sclerosis care.
    Bermel RA; Naismith RT
    Curr Opin Neurol; 2015 Jun; 28(3):244-9. PubMed ID: 25887772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.